Seizure Evolution and Outcome in Pediatric Autoimmune Encephalitis

Area of Science:

• Neurology
• Immunology
• Pediatrics

Background:

• Autoimmune encephalitis (AE) is a significant cause of pediatric neurological disorders.
• Seizures are a common manifestation of pediatric AE, impacting patient outcomes.
• Antibody (Ab) status is crucial in classifying and understanding AE subtypes.

Purpose of the Study:

• To characterize seizure incidence and outcomes in pediatric autoimmune encephalitis (AE).
• To perform subgroup analysis based on antibody (Ab) status.
• To identify risk factors for persistent postencephalitic seizures.

Main Methods:

• Compared seizure characteristics and outcomes in 68 pediatric AE patients with seizures.
• Classified patients into anti-myelin oligodendrocyte glycoprotein (anti-MOG) AE, anti-N-methyl-D-aspartic acid receptor (anti-NMDAR) AE, and Ab-negative AE groups.
• Utilized univariate and multivariate analyses to assess risk factors for postencephalitic seizures.

Main Results:

• Seizure incidence was highest in anti-NMDAR (88.9%) and Ab-negative (71.1%) groups, compared to anti-MOG (37.8%) AE.
• Ab-negative AE patients exhibited higher median seizure frequency and a greater tendency for postencephalitic seizures.
• Ab-negative status was the sole significant predictor of postencephalitic seizures (OR, 4.17).

Conclusions:

• Ab-negative status in pediatric AE predicts a higher seizure burden and less favorable seizure outcomes.
• Anti-N-methyl-D-aspartic acid receptor (anti-NMDAR) and anti-myelin oligodendrocyte glycoprotein (anti-MOG) antibody-positive AE have different seizure profiles.
• Understanding these differences is vital for managing pediatric autoimmune encephalitis.